Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:BCLI
Tag: NASDAQ:BCLI
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Files An 8-K Departure of Directors...
ME Staff 8-k
-
June 26, 2020
0
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Files An 8-K Departure of Directors...
ME Staff 8-k
-
April 3, 2020
0
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Files An 8-K Departure of Directors...
ME Staff 8-k
-
March 13, 2020
0
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Files An 8-K Entry into a...
ME Staff 8-k
-
March 9, 2020
0
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Files An 8-K Submission of Matters...
ME Staff 8-k
-
December 12, 2019
0
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Files An 8-K Departure of Directors...
ME Staff 8-k
-
September 9, 2019
0
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Files An 8-K Regulation FD Disclosure
ME Staff 8-k
-
March 12, 2019
0
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Files An 8-K Departure of Directors...
ME Staff 8-k
-
November 30, 2018
0
Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) price target set to $9.00 by...
ME Staff
-
September 13, 2018
0
Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) price target set to $11.00 by...
ME Staff
-
August 27, 2018
0
1
2
3
Page 1 of 3
